Guided Bone Regeneration Using Bovine-derived Xenograft in Combination With or Without Injectable Platelet-rich Fibrin - Trial NCT04709523
Access comprehensive clinical trial information for NCT04709523 through Pure Global AI's free database. This phase not specified trial is sponsored by Ege University and is currently Completed. The study focuses on Bone Resorption. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ege University
Timeline & Enrollment
N/A
Jan 04, 2017
Nov 23, 2020
Primary Outcome
Augmentation thickness
Summary
The aim of the study was to compare the change in augmentation thickness after guided bone
 regeneration (GBR) using bovine-derived xenograft in combination with or without injectable
 platelet-rich fibrin (i-PRF).
 
 This randomized-controlled clinical trial was conducted on patients with horizontal bone
 deficiency in the posterior regions of mandible. After implant placement, GBR procedures were
 randomly performed using i-PRF enriched bovine-derived xenograft (test group) or bovine
 derived xenograft alone (control group). Cone-beam computed tomography was taken at the
 implant sites immediately, and 6 months after surgery for assess the change in augmentation
 thickness as the primary outcome of the study. The secondary outcomes included marginal bone
 level and implant survival rate.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04709523
Non-Device Trial